15 Ph.D. projects within a Marie Curie - International Training Network (ITN) on virology and immunology
EDGE (Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology) is a Marie Skłodowska-Curie Innovative Training Network for early stage researchers (ESRs) funded by the European Commission under the H2020 Programme, the EU framework programme for research and innovation.
EDGE provides a comprehensive and cross-disciplinary structured curriculum for doctoral students in the fields of virology and immunology. Key research aims of EDGE are to improve the basic understanding of interactions between herpesviruses and host cells and to uncover implications for the clinical outcome of infections as well as development of vaccines. While each ESR is based in a host institution, there are continuous interactions between the involved labs. All positions involve secondments in cooperating laboratories of the network and the participation in a theoretical training program.
|• ESR1:Proteome of cytosolic HSV-1 capsid interactions. (Medizinische Hochschule Hannover, Germany; Supervisor: Beate Sodeik)||Read More|
|• ESR2: Quantitative and qualitative proteome changes after herpesvirus infection (Max Planck Institute, Martinsried, Germany; Supervisor: Andreas Pichlmair)||Read More|
|• ESR3: Functions of EBV-encoded microRNAs in the viral life cycle and in EBV-associated malignancies (University Medical Center Utrecht, The Netherlands; Supervisor: Emmanuel Wiertz)||Read More|
|• ESR4: Cytomegalovirus genetic variability and its interplay with viral DNA sensors (University of Turin, Italy; Supervisor: Santo Landolfo)||Read More|
|• ESR5: Innate antiviral control of herpesvirus infections in vivo (Aarhus University, Denmark; Supervisor: Søren Paludan)||Read More|
|• ESR6: Stimulation of innate immune responses by herpesvirus DNA (Aarhus University, Denmark, Supervisor: Søren Paludan)||Read More|
|• ESR7: Immune responses induced by replication-incompetent HSV-2 (Janssen, Netherlands; Supervisor: Janneke Schuitemaker and Roland Zahn)||Read More|
|• ESR8: Novel primary immunodeficiencies associated with susceptibility to herpes simplex encephalitis (Aarhus University Hospital, Denmark; Supervisor: Trine Mogensen)||Read More|
|• ESR9: DNA sensors in the pathogenesis of autoimmune diseases during herpes infection. (University of Turin, Italy; Supervisor: Santo Landolfo and Marco De Andrea)||Read More|
|• ESR10: Identification and characterization of new cytosolic HSV-1 restriction factors (Medizinische Hochschule Hannover, Germany; Supervisor: Beate Sodeik)||Read More|
|• ESR11: Innate immune sensing and restriction of Varicella zoster virus (University of Oxford, UK; Supervisor: Jan Rehwinkel)||Read More|
|• ESR12: Novel primary immunodeficiencies associated with herpes zoster (Aarhus University Hospital, Denmark; Supervisor: Trine Mogensen)||Read More|
|• ESR13: Identification of novel immune modulatory mechanisms of human cytomegalovirus (Helmholtz Centre for Infection Research, Braunschweig, Germany; Supervisor: Melanie Brinkmann)||Read More|
|• ESR14: Characterisation of the pro- or antiviral role of cellular proteins induced upon infection with Human Cytomegalovirus (Helmholtz Centre for Infection Research, Braunschweig, Germany; Supervisor: Melanie Brinkmann)||Read More|
|• ESR15: Elucidation of herpesvirus evasion mechanisms through CRISPR/Cas-mediated engineering of virus and host genes (University Medical Center Utrecht, The Netherlands; Supervisor: Emmanuel Wiertz)||Read More|
Early Stage Researchers (ESR)
ESRs were, at the time of recruitment by the host organisation, in the first four years* (full-time equivalent research experience) of their research careers and have not yet been awarded a doctoral degree.
* is measured from the date when a researcher obtained the degree which would formally entitle him or her to embark on a doctorate, either in the country in which the degree was obtained or in the country in which the researcher is recruited or seconded, irrespective of whether or not a doctorate is or was ever envisaged.
Innate and Adaptive immunology
Start date for ESR-projects: Sep 1, 2016.
Call has been closed for applications!